Your session is about to expire
← Back to Search
Group II for Osteochondral Defect
Study Summary
This trial tests whether adding a cartilage matrix product to microfracture treatment of ankle cartilage defects improves healing and pain/function.
- Osteochondral Defect
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have experienced severe allergic reactions in the past or have multiple allergies that could potentially cause a severe allergic reaction.Your body mass index (BMI) is less than or equal to 40 kg/m².You have a long-term injury or condition that is not caused by recent sudden injury.You have a fear of confined spaces (claustrophobia) that would make it difficult for you to have an MRI scan of your foot.You need surgery to correct a deformity in your ankle, foot, or heel.Your foot is severely tilted inward or outward by more than a certain amount.You are allergic to products derived from yeast.You use cocaine or drugs made from cocaine.Your ankle has been stable in the past and has similar ligament strength as your other ankle.If you had a broken leg before, it should have healed properly without any permanent changes in the shape of your tibia, fibula, or syndesmosis.You have hindfoot arthritis or deformity and need or have already had surgery to fuse the hindfoot bones.You are allergic to aprotinin.You are currently using nicotine products like gum, patches, cigarettes, cigars, pipe smoking, or chewing tobacco.You have a specific type of bone disorder in your leg called a tibial OCD, either alone or combined with a talar lesion.
- Group 1: Group II
- Group 2: Group I
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment for this study still available to participants?
"Affirmative. The information posted on clinicaltrials.gov verifies that this research is actively seeking participants, with the first posting having been made on January 29th 2019 and most recently updated April 2nd of last year. This study requires 15 individuals to be recruited from 1 medical centre."
How many participants are included in the clinical trial?
"Affirmative. According to information located on clinicaltrials.gov, this medical experiment is still searching for participants since its initial posting on January 29th 2019 and the latest update being April 2nd 2019. The study requires 15 patients from a single location."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger